Effectiveness of third vaccine dose for coronavirus disease 2019 during the Omicron variant pandemic: a prospective observational study in Japan

The administration of a third booster dose of messenger ribonucleic acid (mRNA) vaccines against coronavirus disease 2019 (COVID-19) has progressed worldwide. Since January 2022, Japan has faced a nationwide outbreak caused by the Omicron variant, which occurred simultaneously with the progression o...

Descripción completa

Detalles Bibliográficos
Autores principales: Akaishi, Tetsuya, Kushimoto, Shigeki, Katori, Yukio, Sugawara, Noriko, Egusa, Hiroshi, Igarashi, Kaoru, Fujita, Motoo, Kure, Shigeo, Takayama, Shin, Abe, Michiaki, Kikuchi, Akiko, Ohsawa, Minoru, Ishizawa, Kota, Abe, Yoshiko, Imai, Hiroyuki, Inaba, Yohei, Iwamatsu-Kobayashi, Yoko, Nishioka, Takashi, Onodera, Ko, Ishii, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365759/
https://www.ncbi.nlm.nih.gov/pubmed/35948626
http://dx.doi.org/10.1038/s41598-022-17990-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365759/
https://www.ncbi.nlm.nih.gov/pubmed/35948626
http://dx.doi.org/10.1038/s41598-022-17990-7

Ejemplares similares